
|Articles|October 1, 2004
- Volume 0 0
Gene Discovery May Unlock Key to Obesity Syndrome
Author(s)Susan Farley
Advertisement
Scientists in the United States, Great Britain, and Canada were able to identify the last of 8 genes known to contribute to Bardet-Biedl syndrome (BBS), a rare disorder that combines the common problems of obesity, learning difficulties, diabetes, and asthma. The researchers think that the gene, known as BBS3/ARL6, can be used to understand the other BBS proteins and what causes BBS and, by extension, obesity and other BBS-related problems.
Articles in this issue
almost 22 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationalmost 22 years ago
System Improves Productivity, Drug Verificationalmost 22 years ago
COMPOUNDING HOTLINEalmost 22 years ago
Cardinal Introduces PatientPAK 340Balmost 22 years ago
Obesity Is an Addiction, Researchers Sayalmost 22 years ago
Scientists Seek to Understand How Fat Causes Canceralmost 22 years ago
Government Plans Attack on Obesityalmost 22 years ago
Consuming Fruit, Not Fat, Staves Off Weight Gainalmost 22 years ago
Court Reviews the "Usefulness" of PharmacistsAdvertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Testing categories in practice — clinical conversations
2
FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma
3
COVID-19 Variant Surveillance: A Primer for Pharmacists Navigating Vaccine Questions
4
The Vaccine Schedule Just Changed Again—Here’s What's Real and What Isn't
5





































































































